Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3  (01-2007)

Period of time： 2007年3期

Publisher： Bentham Science Publishers

Founded in： 2007

Total resources： 29

E-ISSN： 2212-2710|1|3

ISSN： 1872-213X

Subject： T-1 Technology Status and Development

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3

Menu

Therapeutic Applications of Antisense Oligonucleotides in Asthma and Allergy

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 171-175

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patents in Targets and Drugs for Unbalanced Cytokine and Chemokine Network Mediated Disorders

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 176-182

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 183-187

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Novel Approaches for Inhibition of Mucus Hypersecretion in Asthma

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 188-192

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Biologic Agents in the Treatment of Psoriasis

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 193-217

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Novel Promising Therapeutic Agents in Multiple Sclerosis

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 218-224

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-01 , pp. 225-231

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Contrast Sensitivity Test in Early Detection of Ocular Changes in the Relation to the Type I Diabetes Mellitus Compensation in Children,Teenagers, and Young Adults

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-01 , pp. 232-236

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Importance of Fibroblasts-Myofibroblasts in Asthma-Induced Airway Remodeling

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 237-241

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patent Selections

Recent Patents on Inflammation & Allergy Drug Discovery,volume 1,issue 3 , Vol. 1, Iss. 3, 2007-11 , pp. 242-246

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)